Bivalirudin therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials

被引：0
|
作者：
Pizzi, C. [1 ]
Costa, G. M. [1 ]
Manzoli, L. [2 ]
Bugiardini, R. [1 ]
机构：
[1] Univ Bologna, Bologna, Italy
[2] Univ G dAnnunzio, Chieti, Italy
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5514
引用
收藏
页码：991 / 991
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
    Nuehrenberg, Thomas G.
    Hochholzer, Willibald
    Mashayekhi, Kambis
    Ferenc, Miroslaw
    Neumann, Franz-Josef
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (09) : 807 - 815
  • [2] Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
    Thomas G. Nührenberg
    Willibald Hochholzer
    Kambis Mashayekhi
    Miroslaw Ferenc
    Franz-Josef Neumann
    [J]. Clinical Research in Cardiology, 2018, 107 : 807 - 815
  • [3] Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
    Valgimigli, Marco
    Biondi-Zoccai, Giuseppe
    Tebaldi, Matteo
    van't Hof, Arnoud W. J.
    Campo, Gianluca
    Hamm, Christian
    ten Berg, Jurrien
    Bolognese, Leonardo
    Saia, Francesco
    Danzi, Gian Battista
    Briguori, Carlo
    Okmen, Ertan
    King, Spencer B.
    Moliterno, David J.
    Topol, Eric J.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (01) : 35 - 49
  • [4] Bivalirudin versus heparin during percutaneous coronary intervention: a meta-analysis of randomized trials
    Cassese, Salvatore
    Byrne, Robert
    Schunkert, Heribert
    Berger, Peter B.
    Kastrati, Adnan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [5] Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes
    Bates E.R.
    [J]. Current Cardiology Reports, 2001, 3 (5) : 348 - 354
  • [6] Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
    Farag, Mohamed
    Gorog, Diana A.
    Prasad, Abhiram
    Srinivasan, Manivannan
    [J]. OPEN HEART, 2015, 2 (01):
  • [7] Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials
    Bavry, Anthony A.
    Elgendy, Islam Y.
    Mahmoud, Ahmed
    Jadhav, Manoj P.
    Huo, Tianyao
    [J]. PLOS ONE, 2015, 10 (05):
  • [8] Bivalirudin versus Heparin for Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Controlled Trials
    Lipinski, Michael J.
    Lhermusier, Thibault
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Magalhaes, Marco A.
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B137 - B137
  • [9] Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials
    Lipinski, Michael J.
    Lhermusier, Thibault
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Magalhaes, Marco A.
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (6-7) : 315 - 322
  • [10] Bivalirudin during percutaneous coronary intervention in acute coronary syndromes
    Laine, Marc
    Lemesle, Gilles
    Dabry, Thibaut
    Panagides, Vassili
    Peyrol, Michael
    Paganelli, Franck
    Bonello, Laurent
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 295 - 304
12345